AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglam GM 1mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Alde Medi Impex Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Voglam GM 1mg/500mg/0.2mg Tablet SR

Diabetic patients using the anti-diabetic combination drug, Voglam GM 1mg/500mg/0.2mg SR tablet, should take it with meals, consistently at the same time daily for optimal blood sugar management. Dosage is determined by your physician and may adjust based on your blood glucose response. Continuous use is crucial; premature discontinuation can lead to uncontrolled blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, encompassing diet, exercise, and weight control as directed by your doctor. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease, pregnant women, or breastfeeding mothers must consult their doctor before use. Regular blood glucose monitoring, along with periodic blood tests to evaluate blood cell counts and liver function, is recommended.

Uses of Voglam GM 1mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Voglam GM 1mg/500mg/0.2mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglam GM 1mg/500mg/0.2mg Extended-Release Tablets should be taken on an empty stomach.

Common Side effects of Voglam GM 1mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglam GM 1mg/500mg/0.2mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Voglam GM 1mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.

How Voglam GM 1mg/500mg/0.2mg Tablet SR works:

Voglam GM extended-release tablets (1mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Voglam GM 1mg/500mg/0.2mg SR tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglam GM 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Voglam GM tablets (1mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Voglam GM 1mg/500mg/0.2mg Tablet SR carries a likely risk for individuals with kidney impairment and is best avoided. Medical advice is recommended. Furthermore, its use is discouraged in cases of severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Voglam GM 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a reduced dosage; the medication is contraindicated in cases of severe liver disease.

What if you forget to take Voglam GM 1mg/500mg/0.2mg Tablet SR :

Should you forget to take a Voglam GM 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglam GM 1mg/500mg/0.2mg Tablet SR

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Voglam GM 1mg/500mg/0.2mg Tablet SR

Voglam GM 1mg/500mg/0.2mg Extended-Release tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults, enhancing glycemic control when combined with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion to reduce blood glucose. Metformin decreases hepatic glucose production and augments insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar. This medication is unsuitable for type 1 diabetes.
Taking Voglam GM 1mg/500mg/0.2mg Tablets SR may cause common adverse reactions including low blood sugar, queasiness, loose stools, taste changes, gas, abdominal discomfort, head pain, skin eruptions, and respiratory illnesses.
Patients with hypersensitivity to Voglam GM 1mg/500mg/0.2mg Tablet SR constituents or inactive ingredients should not take this medication. Its administration is contraindicated in individuals with moderate to severe nephropathy, inflammatory bowel conditions, colonic ulcers, and metabolic acidosis, encompassing diabetic ketoacidosis.
Combining Voglam GM 1mg/500mg/0.2mg SR tablets and alcohol is unsafe. This combination risks lowering blood glucose to dangerously low levels (hypoglycemia) and elevates the possibility of lactic acidosis.
Indeed, Voglam GM 1mg/500mg/0.2mg SR tablets can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic agents. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication within its original, sealed packaging. Follow the storage directions printed on the package or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Voglam GM 1mg/500mg/0.2mg...
73
MRP 89
17% off